Safety of Tazarotene 0.045% Lotion and Hyperpigmentation Improvements in Black Participants With Moderate-to-Severe Acne. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 4, p. s221, 2023. DOI: 10.25251/skin.7.supp.221. Disponível em: https://skin.dermsquared.com/skin/article/view/2200. Acesso em: 18 may. 2025.